Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The next frontier for malaria vaccination

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 618, S20-S22 (2023)

doi: https://doi.org/10.1038/d41586-023-02048-z

This article is part of Nature Outlook: Malaria, an editorially independent supplement produced with the financial support of third parties. About this content.

Updates & Corrections

  • Correction 06 July 2023: This Outlook article erroneously stated that RTS,S is administered to children from the age of 6 weeks. In fact, children must be at least 5 months old.

References

  1. RTS,S Clinical Trials Partnership. Lancet 386, 31–45 (2015).

    Article  PubMed  Google Scholar 

  2. Datoo, M. et al. Lancet Infect Dis. 22, 1728–1736 (2022).

    Article  PubMed  Google Scholar 

  3. Mordmüller, B. et al. Nature 542, 445–449 (2017).

    Article  PubMed  Google Scholar 

  4. Oneko, M. et al. Nature Med. 27, 1636–1645 (2021).

    Article  PubMed  Google Scholar 

  5. Rodriguez, M. et al. PLoS ONE 3, e3300 (2008).

    Article  PubMed  Google Scholar 

  6. Minassian, A. M. et al. Med 2, 701–719 (2021).

    Article  PubMed  Google Scholar 

  7. Silk, S. E. et al. Preprint available at https://doi.org/10.1101/2023.04.17.23288686 (2023).

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links